Biotechnology company 53Biologics, specialized in the development and manufacturing of biologic drugs, has announced the closing of a strategic funding round led by European private equity firm Ren Li...
Read more
Atlas Molecular Pharma (Atlas), a biotechnology company and spin-off of CIC bioGUNE, has closed a €3 million investment round aimed at driving the clinical development of ATL-001, its oral clinical-...
Read more
Nanoligent is a company whose goal is to develop new anticancer drugs specifically targeting aggressive tumors, using a pioneering technological platform based on protein–drug nanoconjugates. The co...
Read more
The transaction includes the participation of Enantia’s management team as shareholders, reinforcing their commitment to the company’s future. The collaboration between Enantia and Inveready will ...
Read more
Medibiofarma, empresa biofarmacéutica navarra que se dedica a descubrir y desarrollar nuevas terapias para enfermedades de alta necesidad médica, ha cerrado una ronda de financiación por valor de u...
Read more
AbilityPharma is currently completing an international Phase 2b clinical trial with its product ABTL0812 in patients with metastatic pancreatic cancer, a disease with a very low survival rate, with th...
Read more
The investment will be used to complete three phase II clinical trials in which the efficacy of its most advanced products is being studied, namely PBF-680 in patients with chronic obstructive pulmona...
Read more
MiMARK Diagnostics, S.L. a pioneering femtech spin-off from the Vall d'Hebron Research Institute (VHIR), has successfully raised €4.22 million as seed round stage. The substantial investment will dr...
Read more
Stereodive Medical es una empresa que nace con una sólida experiencia en el desarrollo de soluciones de software de post-procesado de imágenes. Creemos que aporta un producto innovador, StereoDiver,...
Read more
Carles Domènech, Executive Chairman, Chief Scientific Officer and Co-Founder of AbilityPharma, said: "We are very happy to have reached this agreement with SciClone. This investment represents a cont...
Read more
Sara Secall, a chemistry graduate with a master’s degree in environmental science and an MBA, is the current partner and director of investments in Life Sciences at Inveready, a Venture Capital (VC)...
Read more
The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes the last stage of the investment round with which this year it will ...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...
